| Name | Fenny 1 Pharmacy Llc |
|---|---|
| Organization Name | Fenny I Pharmacy Llc |
| Location | 362 Monroe St, Passaic, New Jersey 07055 |
| Type | Community/Retail Pharmacy |
| Phone | (973) 928-2230 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"Many see their acne go away by the time they reach their 30s," says Jane Liedtka, a medical officer at the Food and Drug Administration (FDA). "But for some, acne persists into their 40s and 50s."
Scientists report in Nature they have found a novel and unexpected molecular switch that could become a key to slowing some of the ravages of getting older as it prompts blood stem cells to age.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.
› Verified 9 days ago
| NPI Number | 1770810574 |
| Organization Name | FENNY I PHARMACY LLC |
| Doing Business As | FENNY 1 PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 362 Monroe St # C, Passaic, NJ 07055 |
| Phone Number | 973-928-2230 |
News Archive
"Many see their acne go away by the time they reach their 30s," says Jane Liedtka, a medical officer at the Food and Drug Administration (FDA). "But for some, acne persists into their 40s and 50s."
Scientists report in Nature they have found a novel and unexpected molecular switch that could become a key to slowing some of the ravages of getting older as it prompts blood stem cells to age.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.
› Verified 9 days ago
News Archive
"Many see their acne go away by the time they reach their 30s," says Jane Liedtka, a medical officer at the Food and Drug Administration (FDA). "But for some, acne persists into their 40s and 50s."
Scientists report in Nature they have found a novel and unexpected molecular switch that could become a key to slowing some of the ravages of getting older as it prompts blood stem cells to age.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.
› Verified 9 days ago
Cvs Pharmacy # 02724 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 394 Broadway Van Houten Ave, Passaic, New Jersey 07055 Phone: (973) 594-4041 | |
Walgreens #05332 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 101 President St, Passaic, New Jersey 07055 Phone: (973) 471-2657 | |
Walgreens#17490 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 78 Main Ave, Passaic, New Jersey 07055 Phone: (973) 778-0510 | |
Health Care Pharmacy Type: Pharmacy Location: 15 Broadway, Passaic, New Jersey 07055 Phone: (973) 473-4444 | |
Passaic Community Pharmacy Inc Type: Community/Retail Pharmacy Location: 339 Passaic St, Passaic, New Jersey 07055 Phone: (973) 471-0160 |